Connecticut Hosts Psilocybin Mushroom Decriminalization Event Forum
On January 10, 2024, the Connecticut for Accessible Psychedelic Medicine (CAPM) held an online and in person forum with lawmakers and experts in Hartford, Connecticut.
The organization, Connecticut for Accessible Psychedelic Medicine (CAPM) hosted an in person and online public forum in regard to psilocybin mushroom decriminalization (1). The event took place between 10am to 12pm EST. From 12pm to 2pm EST, there will be a public comment period offered and takes place in Hartford, the state capitol of Connecticut (1). It can also be viewed on the Connecticut Network where it will be live streamed as well (1).
As mentioned in Psychedelic Week, the invited speakers in the morning session of the event included (1):
- Sarah Gersten, Executive Director of the Last Prisoner Project
- Larry Norris, PhD, Co-founder and National Organizing Director, Decriminalize Nature
- Ismail Ali, JD, Policy Director for the Multidisciplinary Association for Psychedelic studies (MAPS)
- Courtney Barnes, Feldman Legal Associates
- Mason Marks, MD, JD, Visiting Professor of Law, Harvard Law School; Senior Fellow & Project Lead, Project on Psychedelics Law & Regulation (POPLAR)
- Peter Grinspoon, MD, Harvard Medical Doctor
- Erin Doolittle, LMFT Marriage and family therapist
- Kevin Matthews, Denver Psilocybin Mushroom Policy Review Panel; Helix Consulting
- Jared Moffat, New Approach PAC
- Victor Constanza, Samuel Evans, LMSW, and Melissa Keilty, LMSW, Connecticut for Accessible Psychedelic Medicine (CAPM)
In 2023, a bill to decriminalize psilocybin partially in small amounts, passed the Connecticut House by a 86-64 vote (1). Unfortunately, the bill expired before gaining the chance to receive a final vote from the Senate. Representative Steve Stafstrom has plans to reintroduce the bill some time in 2024 (1). If the bill had passed legislation, it would have imposed a $150 fine but end a criminal penalty for having the possession of under a half an ounce of mushrooms. Some concerns have risen to the surface over law enforcement potentially seeking a boost in policing. These concerns have been raised by the New England Veterans for Plant Medicine and Bay Staters for Natural Medicine (1). Hopefully in 2024, the psilocybin decriminalization bill will be passed in the Connecticut Senate and be established into law.
Reference
- Marks, M. CT Lawmakers & Psilocybin Activists to Host Mushroom Decriminalization Forum https://www.psychedelicweek.com/p/connecticut-psilocybin-mushroom-law-policy-forum (accessed Jan 10, 2024).
Collaboration, Gender Diversity, and Progress: Julie Kowalski on Advancing Cannabis Science
December 10th 2024In this interview with Cannabis Science and Technology, Julie Kowalski, an experienced analytical chemist, discusses her path into the cannabis industry, starting with early work in gas chromatography. Kowalski reflects on her perspectives as a female scientist, highlighting biases she’s experienced and the benefits of gender inclusivity in the cannabis space. Greater unity and professionalism could benefit the industry as a whole, she explains. She also encourages collaboration and more women in leadership positions in order to build a stronger scientific community, and also urges women to advocate for themselves, noting that women in cannabis face unique obstacles but often demonstrate consensus-building strategies and solutions.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Gender Diversity and Innovation in the Cannabis Space: Insights from Tess Eidem, PhD
December 9th 2024Cannabis Science and Technology sat down with Tess Eidem, PhD, PCQI, member of Saturn Scientific, LLC, to discuss her journey from antibiotic research to cannabis microbiology and her observations throughout her career. Dr. Eidem highlights challenges women face in this male-dominated industry, including limited representation in leadership roles and frequent experiences of bias and discrimination. She emphasizes the importance of gender diversity in fostering innovation, improving product safety, and addressing women’s health needs in cannabis applications. Her advice to women scientists is to build strong professional relationships and carefully evaluate work environments to advance their careers in this evolving and often challenging space.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.
